Loading…
Clinical, Laboratory, and Pacing Predictors of CRT Response
A decade of research has established the role of cardiac resynchronization therapy (CRT) in medically refractory, moderate to severe systolic heart failure (HF) with intraventricular conduction delay. CRT is an electrical therapy instituted to reestablish ventricular synchronization in order to impr...
Saved in:
Published in: | Journal of cardiovascular translational research 2012-04, Vol.5 (2), p.196-212 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c343t-e13d21275eb94f90035716a1dce6124e8baf50d2893b817c447f53ff4c4efc1d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c343t-e13d21275eb94f90035716a1dce6124e8baf50d2893b817c447f53ff4c4efc1d3 |
container_end_page | 212 |
container_issue | 2 |
container_start_page | 196 |
container_title | Journal of cardiovascular translational research |
container_volume | 5 |
creator | Kandala, Jagdesh Altman, Robert K. Park, Mi Young Singh, Jagmeet P. |
description | A decade of research has established the role of cardiac resynchronization therapy (CRT) in medically refractory, moderate to severe systolic heart failure (HF) with intraventricular conduction delay. CRT is an electrical therapy instituted to reestablish ventricular synchronization in order to improve cardiac function and favorably modulate the neurohormonal system. CRT confers a mortality benefit, improved HF hospitalizations, and functional outcome in this population, but not all patients consistently demonstrate a positive CRT response. The nonresponder rate varies from 20% to 40%, depending on the defined response criteria. Efforts to improve response to CRT have focused on a number of fronts. Methods to optimize the correction of electrical and mechanical dyssynchrony, which is the primary target of CRT, has been the focus of research, in addition to improving patient selection and optimizing post-implant care. However, a major issue in dealing with improving nonresponse rates has been finding an accurate and generally accepted definition of “response” itself. The availability of a standard consensus definition of CRT response would enable the estimation of nonresponder burden accurately and permit the development of strategies to improve CRT response. In this review, we define various aspects of “response” to CRT and outline variability in the definition criteria and the problems with its inconsistencies. We describe clinical, laboratory, and pacing predictors that influence CRT response and outcome and how to optimize response. |
doi_str_mv | 10.1007/s12265-012-9352-0 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_926642409</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>926642409</sourcerecordid><originalsourceid>FETCH-LOGICAL-c343t-e13d21275eb94f90035716a1dce6124e8baf50d2893b817c447f53ff4c4efc1d3</originalsourceid><addsrcrecordid>eNp9kD1rwzAQhkVpadK0P6BL8dYlbnX6sCw6FdMvCDSEdBayLAUHx0qleMi_j4PTjJ3uuHvuhXsQugf8BBiL5wiEZDzFQFJJOUnxBRqDpCLlVPLLc5-LEbqJcY1xRrAQ12hECM0I5DBGL0VTt7XRzTSZ6dIHvfNhP010WyVzbep2lcyDrWrTj2PiXVIslsnCxq1vo71FV0430d6d6gT9vL8ti8909v3xVbzOUkMZ3aUWaEWACG5LyZzEmHIBmYbK2AwIs3mpHccVySUtcxCGMeE4dY4ZZp2Bik7Q45C7Df63s3GnNnU0tml0a30XlSRZxgjDsidhIE3wMQbr1DbUGx32CrA6KlODMtUrU0dlCvc3D6f0rtzY6nzx56gHyADEftWubFBr34W2__if1AP3rnS6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>926642409</pqid></control><display><type>article</type><title>Clinical, Laboratory, and Pacing Predictors of CRT Response</title><source>Springer Nature</source><creator>Kandala, Jagdesh ; Altman, Robert K. ; Park, Mi Young ; Singh, Jagmeet P.</creator><creatorcontrib>Kandala, Jagdesh ; Altman, Robert K. ; Park, Mi Young ; Singh, Jagmeet P.</creatorcontrib><description>A decade of research has established the role of cardiac resynchronization therapy (CRT) in medically refractory, moderate to severe systolic heart failure (HF) with intraventricular conduction delay. CRT is an electrical therapy instituted to reestablish ventricular synchronization in order to improve cardiac function and favorably modulate the neurohormonal system. CRT confers a mortality benefit, improved HF hospitalizations, and functional outcome in this population, but not all patients consistently demonstrate a positive CRT response. The nonresponder rate varies from 20% to 40%, depending on the defined response criteria. Efforts to improve response to CRT have focused on a number of fronts. Methods to optimize the correction of electrical and mechanical dyssynchrony, which is the primary target of CRT, has been the focus of research, in addition to improving patient selection and optimizing post-implant care. However, a major issue in dealing with improving nonresponse rates has been finding an accurate and generally accepted definition of “response” itself. The availability of a standard consensus definition of CRT response would enable the estimation of nonresponder burden accurately and permit the development of strategies to improve CRT response. In this review, we define various aspects of “response” to CRT and outline variability in the definition criteria and the problems with its inconsistencies. We describe clinical, laboratory, and pacing predictors that influence CRT response and outcome and how to optimize response.</description><identifier>ISSN: 1937-5387</identifier><identifier>EISSN: 1937-5395</identifier><identifier>DOI: 10.1007/s12265-012-9352-0</identifier><identifier>PMID: 22362181</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Biomedical Engineering and Bioengineering ; Biomedicine ; Cardiac Resynchronization Therapy ; Cardiology ; Electrocardiography ; Global Health ; Heart Failure - mortality ; Heart Failure - physiopathology ; Heart Failure - therapy ; Heart Ventricles - physiopathology ; Human Genetics ; Humans ; Medicine ; Medicine & Public Health ; Prognosis ; Survival Rate - trends ; Treatment Outcome</subject><ispartof>Journal of cardiovascular translational research, 2012-04, Vol.5 (2), p.196-212</ispartof><rights>Springer Science+Business Media, LLC 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c343t-e13d21275eb94f90035716a1dce6124e8baf50d2893b817c447f53ff4c4efc1d3</citedby><cites>FETCH-LOGICAL-c343t-e13d21275eb94f90035716a1dce6124e8baf50d2893b817c447f53ff4c4efc1d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22362181$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kandala, Jagdesh</creatorcontrib><creatorcontrib>Altman, Robert K.</creatorcontrib><creatorcontrib>Park, Mi Young</creatorcontrib><creatorcontrib>Singh, Jagmeet P.</creatorcontrib><title>Clinical, Laboratory, and Pacing Predictors of CRT Response</title><title>Journal of cardiovascular translational research</title><addtitle>J. of Cardiovasc. Trans. Res</addtitle><addtitle>J Cardiovasc Transl Res</addtitle><description>A decade of research has established the role of cardiac resynchronization therapy (CRT) in medically refractory, moderate to severe systolic heart failure (HF) with intraventricular conduction delay. CRT is an electrical therapy instituted to reestablish ventricular synchronization in order to improve cardiac function and favorably modulate the neurohormonal system. CRT confers a mortality benefit, improved HF hospitalizations, and functional outcome in this population, but not all patients consistently demonstrate a positive CRT response. The nonresponder rate varies from 20% to 40%, depending on the defined response criteria. Efforts to improve response to CRT have focused on a number of fronts. Methods to optimize the correction of electrical and mechanical dyssynchrony, which is the primary target of CRT, has been the focus of research, in addition to improving patient selection and optimizing post-implant care. However, a major issue in dealing with improving nonresponse rates has been finding an accurate and generally accepted definition of “response” itself. The availability of a standard consensus definition of CRT response would enable the estimation of nonresponder burden accurately and permit the development of strategies to improve CRT response. In this review, we define various aspects of “response” to CRT and outline variability in the definition criteria and the problems with its inconsistencies. We describe clinical, laboratory, and pacing predictors that influence CRT response and outcome and how to optimize response.</description><subject>Biomedical Engineering and Bioengineering</subject><subject>Biomedicine</subject><subject>Cardiac Resynchronization Therapy</subject><subject>Cardiology</subject><subject>Electrocardiography</subject><subject>Global Health</subject><subject>Heart Failure - mortality</subject><subject>Heart Failure - physiopathology</subject><subject>Heart Failure - therapy</subject><subject>Heart Ventricles - physiopathology</subject><subject>Human Genetics</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Prognosis</subject><subject>Survival Rate - trends</subject><subject>Treatment Outcome</subject><issn>1937-5387</issn><issn>1937-5395</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp9kD1rwzAQhkVpadK0P6BL8dYlbnX6sCw6FdMvCDSEdBayLAUHx0qleMi_j4PTjJ3uuHvuhXsQugf8BBiL5wiEZDzFQFJJOUnxBRqDpCLlVPLLc5-LEbqJcY1xRrAQ12hECM0I5DBGL0VTt7XRzTSZ6dIHvfNhP010WyVzbep2lcyDrWrTj2PiXVIslsnCxq1vo71FV0430d6d6gT9vL8ti8909v3xVbzOUkMZ3aUWaEWACG5LyZzEmHIBmYbK2AwIs3mpHccVySUtcxCGMeE4dY4ZZp2Bik7Q45C7Df63s3GnNnU0tml0a30XlSRZxgjDsidhIE3wMQbr1DbUGx32CrA6KlODMtUrU0dlCvc3D6f0rtzY6nzx56gHyADEftWubFBr34W2__if1AP3rnS6</recordid><startdate>20120401</startdate><enddate>20120401</enddate><creator>Kandala, Jagdesh</creator><creator>Altman, Robert K.</creator><creator>Park, Mi Young</creator><creator>Singh, Jagmeet P.</creator><general>Springer US</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120401</creationdate><title>Clinical, Laboratory, and Pacing Predictors of CRT Response</title><author>Kandala, Jagdesh ; Altman, Robert K. ; Park, Mi Young ; Singh, Jagmeet P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c343t-e13d21275eb94f90035716a1dce6124e8baf50d2893b817c447f53ff4c4efc1d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Biomedical Engineering and Bioengineering</topic><topic>Biomedicine</topic><topic>Cardiac Resynchronization Therapy</topic><topic>Cardiology</topic><topic>Electrocardiography</topic><topic>Global Health</topic><topic>Heart Failure - mortality</topic><topic>Heart Failure - physiopathology</topic><topic>Heart Failure - therapy</topic><topic>Heart Ventricles - physiopathology</topic><topic>Human Genetics</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Prognosis</topic><topic>Survival Rate - trends</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kandala, Jagdesh</creatorcontrib><creatorcontrib>Altman, Robert K.</creatorcontrib><creatorcontrib>Park, Mi Young</creatorcontrib><creatorcontrib>Singh, Jagmeet P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cardiovascular translational research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kandala, Jagdesh</au><au>Altman, Robert K.</au><au>Park, Mi Young</au><au>Singh, Jagmeet P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical, Laboratory, and Pacing Predictors of CRT Response</atitle><jtitle>Journal of cardiovascular translational research</jtitle><stitle>J. of Cardiovasc. Trans. Res</stitle><addtitle>J Cardiovasc Transl Res</addtitle><date>2012-04-01</date><risdate>2012</risdate><volume>5</volume><issue>2</issue><spage>196</spage><epage>212</epage><pages>196-212</pages><issn>1937-5387</issn><eissn>1937-5395</eissn><abstract>A decade of research has established the role of cardiac resynchronization therapy (CRT) in medically refractory, moderate to severe systolic heart failure (HF) with intraventricular conduction delay. CRT is an electrical therapy instituted to reestablish ventricular synchronization in order to improve cardiac function and favorably modulate the neurohormonal system. CRT confers a mortality benefit, improved HF hospitalizations, and functional outcome in this population, but not all patients consistently demonstrate a positive CRT response. The nonresponder rate varies from 20% to 40%, depending on the defined response criteria. Efforts to improve response to CRT have focused on a number of fronts. Methods to optimize the correction of electrical and mechanical dyssynchrony, which is the primary target of CRT, has been the focus of research, in addition to improving patient selection and optimizing post-implant care. However, a major issue in dealing with improving nonresponse rates has been finding an accurate and generally accepted definition of “response” itself. The availability of a standard consensus definition of CRT response would enable the estimation of nonresponder burden accurately and permit the development of strategies to improve CRT response. In this review, we define various aspects of “response” to CRT and outline variability in the definition criteria and the problems with its inconsistencies. We describe clinical, laboratory, and pacing predictors that influence CRT response and outcome and how to optimize response.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>22362181</pmid><doi>10.1007/s12265-012-9352-0</doi><tpages>17</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1937-5387 |
ispartof | Journal of cardiovascular translational research, 2012-04, Vol.5 (2), p.196-212 |
issn | 1937-5387 1937-5395 |
language | eng |
recordid | cdi_proquest_miscellaneous_926642409 |
source | Springer Nature |
subjects | Biomedical Engineering and Bioengineering Biomedicine Cardiac Resynchronization Therapy Cardiology Electrocardiography Global Health Heart Failure - mortality Heart Failure - physiopathology Heart Failure - therapy Heart Ventricles - physiopathology Human Genetics Humans Medicine Medicine & Public Health Prognosis Survival Rate - trends Treatment Outcome |
title | Clinical, Laboratory, and Pacing Predictors of CRT Response |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T15%3A07%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical,%20Laboratory,%20and%20Pacing%20Predictors%20of%20CRT%20Response&rft.jtitle=Journal%20of%20cardiovascular%20translational%20research&rft.au=Kandala,%20Jagdesh&rft.date=2012-04-01&rft.volume=5&rft.issue=2&rft.spage=196&rft.epage=212&rft.pages=196-212&rft.issn=1937-5387&rft.eissn=1937-5395&rft_id=info:doi/10.1007/s12265-012-9352-0&rft_dat=%3Cproquest_cross%3E926642409%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c343t-e13d21275eb94f90035716a1dce6124e8baf50d2893b817c447f53ff4c4efc1d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=926642409&rft_id=info:pmid/22362181&rfr_iscdi=true |